| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/11/2002 | US20020091279 15R-5,6,15-trihydroxy-7,9,13-trans- 11-cis-eicosatetraenoic oracid,15R-5,14,15-trihydroxy-6,10,12-trans-8-cis-eicosatetraenoic acid, or 15-hydroxyeicosatetraenoic acid; anticarcinogenic agents |
| 07/11/2002 | US20020091278 Steroid derived antibiotics |
| 07/11/2002 | US20020091273 Method for the regioselective preparation of substituted benzo[g]quinoline3-carbonitriles and benzo[g]quinazolines |
| 07/11/2002 | US20020091272 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/11/2002 | US20020091270 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 07/11/2002 | US20020091269 Synthesis of epothilones and related analogs |
| 07/11/2002 | US20020091266 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/11/2002 | US20020091265 4-phenyl-pyridine derivatives |
| 07/11/2002 | US20020091263 Biaryl substituted purine derivatives as potent antiproliferative agents |
| 07/11/2002 | US20020091262 Armoatic or heteroarmoatic compound containing substituted amides or thioamides |
| 07/11/2002 | US20020091261 Phthalazines with angiogenesis inhibiting activity |
| 07/11/2002 | US20020091251 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product |
| 07/11/2002 | US20020091244 Nucleotide sequences for use in diagnosis and treatment of cancer and immunological disorders |
| 07/11/2002 | US20020091236 Nucleotide sequences coding preferential polypeptide for use in detection of bactericides |
| 07/11/2002 | US20020091230 Made from a bis/gamma-hydroxyhydrocarbyl/ ester of terephthalic acid and a phosphorodichloridate; biocompatible before and upon biodegradation |
| 07/11/2002 | US20020091162 Migraine medicine and method of treating the same without caffeine |
| 07/11/2002 | US20020091161 Novel long acting, reversible veterinary sedative & analgesic and method of use |
| 07/11/2002 | US20020091160 Administering orally a source of at least one of L-arginine and L-lysine as other than a natural food source |
| 07/11/2002 | US20020091158 Composition for and method of treatment using triterpenoids |
| 07/11/2002 | US20020091157 Cyclic GMP (cGMP)-specific phosphodiesterase (PDE) inhibitor (e.g., exisulind) to reduce the side effects or increase the efficacy of treatment with an antineoplastic platinum coordination complex like cisplatin or carboplatin. |
| 07/11/2002 | US20020091156 Novel arginine/ascorbic acid mixed powder as an oral supplement |
| 07/11/2002 | US20020091155 Oxandrolone is administered, preferably in a daily dosage in the range of about 2.5-30 milligrams. |
| 07/11/2002 | US20020091153 Novel anandamide amidase inhibitors as analgesic agents |
| 07/11/2002 | US20020091152 Medicament for treatment of irritable bowel syndrome |
| 07/11/2002 | US20020091150 Carbamic acid derivatives |
| 07/11/2002 | US20020091148 3-substituted indole antiproliferative angiogenesis inhibitors |
| 07/11/2002 | US20020091147 Substituted-phenyl ketone derivatives as ip antagonists |
| 07/11/2002 | US20020091146 Administering effective amount of an agent that inhibits a glomerular cytochrome P450; reduction of proteinuria |
| 07/11/2002 | US20020091145 Behavior chemotherapy |
| 07/11/2002 | US20020091144 Treatment of apoptotic cell death |
| 07/11/2002 | US20020091143 Use of 4-substituted tetrahydropyridines for the manufacture of medicament s acting upon TGF-beta 1 |
| 07/11/2002 | US20020091142 Therapeutic or prophylactic treatment of transplant rejection and inflammatory and autoimmune diseases. |
| 07/11/2002 | US20020091140 Method of treating and preventing migraine headaches |
| 07/11/2002 | US20020091139 Treatment of inflammatory pulmonary disease states, especially reduction of allergic antibody production; antiasthmatics |
| 07/11/2002 | US20020091138 Treating vascular proliferative disorders |
| 07/11/2002 | US20020091137 Use of CCI-779 as an antineoplastic agent |
| 07/11/2002 | US20020091136 Pharmaceutical compositions containing cinchonine dichlorhydrate |
| 07/11/2002 | US20020091134 Novel 4-phenyl substituted tetrahydroiso quinolines therapeutic use thereof |
| 07/11/2002 | US20020091133 Includes proliferation of neural stem and progenitor cells, differentiation of these cells into neurons, and/or survival of these new neurons; preferred compound is N4-((3-(6-oxo-1,6-dihydropurin-9-yl)-1-oxopropyl)amino)benzoic acid |
| 07/11/2002 | US20020091132 Composition and method comprising CPT-11 and a pyrimidine derivative for the treatment of cancer |
| 07/11/2002 | US20020091130 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof |
| 07/11/2002 | US20020091129 Treatment of premature ejaculation |
| 07/11/2002 | US20020091128 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 07/11/2002 | US20020091127 Semicarbazides and their uses |
| 07/11/2002 | US20020091126 Folate compound or derivative (such as tetrahydrohydrofolate or 5-methyltetrahydrofolate), tetrahydrobiopterin or mixtures |
| 07/11/2002 | US20020091124 Also used as an antimitotic and for direct and/or indirect inhibition of tubulin polymerization in mammalian |
| 07/11/2002 | US20020091123 Administered during and after surgical removal of a cancerous tumor to treat abdominal cancer. |
| 07/11/2002 | US20020091122 Voltage-dependent |
| 07/11/2002 | US20020091121 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 07/11/2002 | US20020091119 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/11/2002 | US20020091118 Psychotherapeutic agents. |
| 07/11/2002 | US20020091117 Psychotherapeutic agents. |
| 07/11/2002 | US20020091114 Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity |
| 07/11/2002 | US20020091113 Treatment of septic shock |
| 07/11/2002 | US20020091111 Bile salt conjugates |
| 07/11/2002 | US20020091110 Dietary compositions |
| 07/11/2002 | US20020091108 Stable salts of O-acetylsalicylic acid with basic amino acids |
| 07/11/2002 | US20020091105 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 07/11/2002 | US20020091104 Protein tyrosine phosphatases inhibitors, especially as antidiabetic agents |
| 07/11/2002 | US20020091103 Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder |
| 07/11/2002 | US20020091100 Also cromolyn salts or esters; may be in combination with a corticosteroid; may also contain an antiphlogistic compound and hyaluronic acid |
| 07/11/2002 | US20020091099 Orally active a1 adenosine receptor agonists |
| 07/11/2002 | US20020091098 Also administering to the subject an effective amount of an mda-7 protein. |
| 07/11/2002 | US20020091097 Nucleic acids for the prevention and treatment of sexually transmitted diseases |
| 07/11/2002 | US20020091095 Modulation of Fas and FasL expression |
| 07/11/2002 | US20020091092 Use of propionyl L-carnitine for the preparation of a medicament capable of inducing apoptosis |
| 07/11/2002 | US20020091091 Method and compositions for solubilization of pentacyclic triterpenes |
| 07/11/2002 | US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 07/11/2002 | US20020091088 Administration of at least one agent at a level which enhances NO and which does not appreciably alter normal systemic vascular tone |
| 07/11/2002 | US20020091087 Prevention and treatment of degenerative diseases by glutathione and phase II detoxification enzymes |
| 07/11/2002 | US20020091078 Treating diabetes, especially Type II diabetes |
| 07/11/2002 | US20020091075 Administering a kappa opioid receptor antagonist |
| 07/11/2002 | US20020090732 Modulator for use in the treatment of brain, psychological and nervous system disorders |
| 07/11/2002 | US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 07/11/2002 | US20020090673 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090672 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090622 Detection of a polymorphism in a sodium transport protein; obtain sample, recover nucleotide sequences from sample, determine nucleotide sequences of sample, compare to control |
| 07/11/2002 | US20020090610 Polypeptide for use in the detection, diagnosis, prevention and treatment of vial disease |
| 07/11/2002 | US20020090609 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 07/11/2002 | US20020090441 Phytopharmaceutical food products or integrators |
| 07/11/2002 | US20020090405 For inhibiting cell proliferation |
| 07/11/2002 | US20020090404 Therapy of atherosclerosis and hypercholesterolemia with canola extracts |
| 07/11/2002 | US20020090403 Antidepressant |
| 07/11/2002 | US20020090397 Novel suppository form comprising an acid-labile active compound |
| 07/11/2002 | US20020090396 Administering a sustained release pharmaceutical dosage form including ranolazine for therapy of cardiovascular disease selected from arrhythmias, variant and exercise-induced angina, and myocardial infarction |
| 07/11/2002 | US20020090395 Anti-inflammatory pharmaceutical formulations |
| 07/11/2002 | US20020090394 Paroxetine controlled release compositions |
| 07/11/2002 | US20020090390 Device and method for treating urinary incontinence in females |
| 07/11/2002 | US20020090388 Implantable, for sustained delivery of a drug directly into systemic circulation of an animal |
| 07/11/2002 | US20020090387 Insecticidal combination to control mammal fleas in particular fleas in particular fleas on cats and dogs |
| 07/11/2002 | US20020090384 Anti-irritant compositions containing a cyclic nucleotide |
| 07/11/2002 | US20020090377 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | US20020090362 Immunotherapy using cytotoxic t lymphocytes (ctl) |
| 07/11/2002 | US20020090357 Contacting a naive T cell with a stimulatory signal and an appropriate amount of a combination of Vitamin D3 and Dexamethasone, wherein contacting results in differentiation to a regulatory T cell |
| 07/11/2002 | US20020090352 Compositions and methods for use in modulating immune system function |
| 07/11/2002 | DE10063885A1 Drug formulation useful e.g. for treating angina or hypertension contains thieno (2,3-d) pyrimidine derivative phosphodiesterase V inhibitor and antithrombotic agent, calcium antagonist or prostaglandin, |
| 07/11/2002 | DE10063882A1 Drug formulation useful e.g. for treating angina or hypertension contains pyrazolo (4,3-d) pyrimidine derivative phosphodiesterase V inhibitor and antithrombotic agent, calcium antagonist or prostaglandin |
| 07/11/2002 | DE10054783A1 Pharmaceutical compositions useful as female contraceptives which are effective at low doses and do not cause the side-effects, contain thyroid hormone |
| 07/11/2002 | CA2558640A1 Spliceosome mediated rna trans-splicing |